Full-Time

External Workforce Centre Senior Manager

Confirmed live in the last 24 hours

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

No salary listed

Senior, Expert

Hyderabad, Telangana, India

Category
Generalist Operations
Procurement & Sourcing
Operations & Logistics
Required Skills
Tableau
Requirements
  • Bachelor’s degree in Human Resources, Business, Life Sciences, or related field (MBA or MS preferred)
  • 8–12 years of experience managing external workforce programs, with 3+ years in life sciences or biotech preferred
  • Deep expertise in contingent workforce models and VMS tools (Fieldglass, Beeline)
  • Strong knowledge of regulatory and compliance frameworks (e.g., SOX, GxP, FDA)
  • Proven success leading cross-functional programs and influencing senior stakeholders.
Responsibilities
  • Develop and implement an enterprise-wide external workforce strategy aligned with scientific, clinical, and operational goals.
  • Establish and maintain governance frameworks, policies, and compliance standards in partnership with Legal, HR, Procurement, and department leaders.
  • Oversee the full lifecycle of the external workforce—including sourcing, onboarding, tracking, and offboarding via VMS such as SAP Fieldglass.
  • Manage key vendor relationships (CROs, staffing firms, consultants), ensuring high performance and cost-effectiveness.
  • Partner with regional and functional leads on continuous improvement initiatives.
  • Ensure adherence to labor laws, co-employment risks, GxP, and FDA/EMA requirements.
  • Serve as process owner for SOX audits, including execution of monthly controls and support for audit readiness.
  • Lead development of dashboards and reporting tools (e.g., Tableau, Alteryx) to monitor cost, utilization, and workforce trends.
  • Provide insights and recommendations to senior leadership to inform strategic workforce planning.
  • Act as a trusted advisor to business leaders across various functions.
  • Mentor and manage a team (where applicable), and champion process standardization, scalability, and operational excellence.
  • Support change management, training, and policy adherence across the organization.
Desired Qualifications
  • MBA or MS preferred
  • 3+ years in life sciences or biotech preferred

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are derived from living organisms, to address conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen's products work by utilizing biological processes to create effective treatments for patients. Unlike many competitors, Amgen emphasizes a strong commitment to research and development, reinvesting a large portion of its earnings to discover new therapies. The goal of Amgen is to improve patient care and outcomes by providing effective therapeutic solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of Micromet boosts Amgen's oncology portfolio with BiTE antibody blinatumomab.
  • Institutional investments indicate strong confidence in Amgen's financial health and prospects.
  • Amgen's AI-driven drug discovery investments could accelerate R&D capabilities.

What critics are saying

  • Micromet acquisition may face clinical or regulatory challenges impacting strategic goals.
  • Investor pressure for short-term gains may affect long-term R&D investments.
  • FTC scrutiny on mergers could hinder Amgen's future strategic growth.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline in oncology, cardiovascular, and autoimmune disorders.
  • Amgen's strategic acquisitions enhance its innovative medicine portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

Amgen
Jun 2nd, 2025
Amgen to Acquire Micromet| Amgen

The acquisition includes blinatumomab, a Bispecific T cell Engager (BiTE) antibody in Phase 2 clinical development for acute lymphoblastic leukemia (ALL). Blinatumomab is also in clinical development for the treatment of non-Hodgkin's lymphoma (NHL), and could have applications in other hematologic malignancies.

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.